WORLD’S FIRST
Hand Carriable CLIA Based COVID-19 Diagnostic Solution
4TH Generation Point-Of-Care Testing – Microfluidic Chemiluminescence

Innovative Technology – Lab-On-A-Chip
Magnetic separation enzymatic chemiluminescence
6 different reagents integrating all in one chip
Unique re-quantitative measuring design
Patented built-in blood filter

Bee Covid_19 Testing Machines – M2 & M5 Chemiluminescence Immunoassay

Focus On Acute Care Applications
Emergency lab/Ambulance/ICU/CCU/Chest pain centre/ Cardiology/Pediatrics…
M2 & M5 system enables reducing turnaround time (TAT) significantly.
It perfectly complies with central lab chemiluminescence method & third-party control.
Unique accurate fingertip whole blood PCT perfectly applies to pediatric patients.
9 stepping motors enable complex chemiluminescence reactions on the chip
WORLD’S SMALEST Chemiluminescence Analyzers

M2 Single Channel Chemiluminescence Immunoassay

Machine Details

Hand carriable (4.5kg)
7’ touch screen
Free Maintenance
Enable to connect with LIS/HIS
Built-in GPS, 4G, WIFI, Bluetooth
Thermostat maintains 37C Reaction Environment
Auto calibration & parameter settings via QR code
M5 Four Channels Chemiluminescence Immunoassay

Machine Details

Compact CLIA
4 independent channels
11.6’ foldable touch screen
Free Maintenance
Enable to connect with LIS/HIS
Built-in GPS, 4G, WIFI, Bluetooth
Thermostat maintains 37C Reaction Environment
Auto calibration & parameter settings via QR code
SARS-CoV-2 Ag/Ab/IgG/IgM Diagnostic Test Kit – (Microfluidic Chemiluminescence)
Reduce Window Period of Testing
Improve Positive Detection Rates
Minimize Infection Risk

Microfluidic Reagent Chip – Test Kit

Completely sealed reaction chips avoid blood sample cross contamination to protect medical professionals.
Test Value
SARS-CoV-2 Ag A part of virus & earliest biomarker
Direct proof of SARS-CoV-2 infection
SARS-CoV-2 lgM The first antibody appeared in blood
Detectable in 3-5 days after onset
SARS-CoV-2 IgG Most abundant part of total antibodies
Enable to be detected most easily
SARS-CoV-2 Total Antibody Includes IgG, IgM, IgA, IgD and IgE
The most sensitive and earliest Ab indicator

Result Interpretation
Healthy People | Early Stage of COVID-19 | Middle Stage of COVID-19 | Recovery Stage of COVID-19 | |
SARS-CoV-2 Ag | – | +/- | +/- | +/- |
SARS-CoV-2 IgM | – | +/- | +/- | – |
SARS-CoV-2 IgG | – | – | +/- | + |
SARS-CoV-2 Ab | – | +/- | + | + |
Ab detections are recommended by Chinese Guidance for COVID-19 |
Chinese Clinical Guidance for COVID-19 Diagnosis and Treatment (7th edition) 5. Diagnostic criteria
(b) Confirmed cases
Suspected cases with one of the following etiology or serological evidence can be identified as confirmed cases:
(3) The COVID-19 specific IgM and IgM and IgG antibodies are tested positive. The titer of COVID-19 specific IgG antibody is 4 times higher in recovery period than that in acute phase.
9. Identifying cases and filing reports
If COVID-19 nucleic acid tests are negative for two consecutive times (with at least 24 hours interval between each test), and if COVID-19-specific IgM and IgG antibodies remain negative after 7 days from onset, the suspected diagnosis of COVID-19 can be ruled out.
Features
Gold Standard Method
Magnetic separation enzymatic chemiluminescence.
Minisize CLIA Analyzer
Only 4.5kg, Easy to move
Easy access to biosafety cabinet
Safe
Whole blood samples no need centrifugation
Minimize sample exposure to lab environment
Single dose & completely sealed cartridge reduce infection risk
Accurate
High sensitivity & specificity of immunoassay
Avoid high false negative rate of RT-PCR
Rapid
Results in only 15 minutes
No need RNA extraction
3 Easy Steps To Operate

Confidence In Performance – Golden Standard – Chemiluminescence

Multi-Level Quality Control
Excellent traceability with chemiluminescence
Automatic self-check system
Optic signal calibration chips
3-level liquid QC
External third party QC

Patient Care Management System
Built-in communication modules: GPS, 4G, WIFI, Bluetooth, iCloud
Acute care specialized management software enables locating analyzers, managing operators, online quality control, service support and integrating multiple POC instruments.

Test Menu
PARAMETERS | SAMPLE TYPE | SAMPLE VOLUME | TESTING TIME |
SARS – CoV- 2 Ag | Serum, Plasma, Whole blood, Throat Swab, Urine | 40μl | 15 mins |
SARS – CoV-2 IgG Ab | Serum, Plasma, Whole blood | 20μl | 15 mins |
SARS-CoV-2 IgM Ab | Serum, Plasma, Whole blood | 20μl | 15 mins |
SARS – CoV-2 Ab | Serum, Plasma, Whole blood | 20μl | 15 mins |
Specification
CHEMILUMINESCENCE ANALYZERS
Model No. | M2 | M5 |
Dimension | 267.5mm x 180 mm x 220mm | 290mm x 229mm x 350mm |
Weight | 4.5kg | 10kg |
KW | 300VA | 250VA |
Input Power | AC 100V-240V 50/60Hz | AC 100V-240V 50/60Hz |
MICROFLUIDIC REAGENT CHIP
Testing Time | 10-15min/test |
Sample Type | Whole blood/ peripheral blood/ plasma/ serum |
Sample Volume | 5-50μl |
Intellectual Property
TYPE | GRANTED | ISSUED | UPCOMING APPLICATIONS |
Invention | 17 | 18 | 8 |
Utility Model | 22 | 15 | 11 |
Software Copyright | 5 | 2 | 1 |
Trademark | 4 | / | / |
PTC | / | 6 | 3 |
Total | 55 | 40 | 29 |